Cargando…

Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness

Despite many years of research efforts, lung cancer still remains the leading cause of cancer deaths worldwide. Objective of this study was to set up a platform of non-small cell lung cancer patient derived xenografts (PDXs) faithfully representing primary tumour characteristics and offering a uniqu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moro, Massimo, Bertolini, Giulia, Caserini, Roberto, Borzi, Cristina, Boeri, Mattia, Fabbri, Alessandra, Leone, Giorgia, Gasparini, Patrizia, Galeone, Carlotta, Pelosi, Giuseppe, Roz, Luca, Sozzi, Gabriella, Pastorino, Ugo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532258/ https://www.ncbi.nlm.nih.gov/pubmed/28751748 http://dx.doi.org/10.1038/s41598-017-06912-7

Ejemplares similares

Author Correction: Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness
por: Moro, Massimo, et al.
Publicado: (2018)

Conversion to stem‐cell state in response to microenvironmental cues is regulated by balance between epithelial and mesenchymal features in lung cancer cells
por: Andriani, Francesca, et al.
Publicado: (2015)

Patient-Derived Xenografts of Non Small Cell Lung Cancer: Resurgence of an Old Model for Investigation of Modern Concepts of Tailored Therapy and Cancer Stem Cells
por: Moro, Massimo, et al.
Publicado: (2012)

Combination Treatment with All-Trans Retinoic Acid Prevents Cisplatin-Induced Enrichment of CD133(+) Tumor-Initiating Cells and Reveals Heterogeneity of Cancer Stem Cell Compartment in Lung Cancer
por: Moro, Massimo, et al.
Publicado: (2015)

MiR-486-5p Targets CD133+ Lung Cancer Stem Cells through the p85/AKT Pathway
por: Moro, Massimo, et al.
Publicado: (2022)

Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening
por: Sestini, Stefano, et al.
Publicado: (2015)

Correction: Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening
por: Sestini, Stefano, et al.
Publicado: (2019)

Establishment of 6 pediatric rhabdomyosarcoma patient’s derived xenograft models closely recapitulating patients’ tumor characteristics
por: Gasparini, Patrizia, et al.
Publicado: (2022)

Gene Signatures Stratify Computed Tomography Screening Detected Lung Cancer in High-Risk Populations()
por: Hu, Jiangting, et al.
Publicado: (2015)

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening
por: Mensah, Mavis, et al.
Publicado: (2017)

MicroRNA Profile of Lung Tumor Tissues Is Associated with a High Risk Plasma miRNA Signature
por: Fortunato, Orazio, et al.
Publicado: (2016)

Exo-miRNAs as a New Tool for Liquid Biopsy in Lung Cancer
por: Fortunato, Orazio, et al.
Publicado: (2019)

Mutational Profile from Targeted NGS Predicts Survival in LDCT Screening-Detected Lung Cancers
por: Verri, Carla, et al.
Publicado: (2017)

Circulating mir‐320a promotes immunosuppressive macrophages M2 phenotype associated with lung cancer risk
por: Fortunato, Orazio, et al.
Publicado: (2019)

Extracellular vesicles from subjects with COPD modulate cancer initiating cells phenotype through HIF-1α shuttling
por: Petraroia, Ilaria, et al.
Publicado: (2023)

Assessment of Circulating microRNAs in Plasma of Lung Cancer Patients
por: Fortunato, Orazio, et al.
Publicado: (2014)

Circulating extracellular vesicles from individuals at high-risk of lung cancer induce pro-tumorigenic conversion of stromal cells through transfer of miR-126 and miR-320
por: Pontis, Francesca, et al.
Publicado: (2021)

Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction
por: Fortunato, O, et al.
Publicado: (2014)

Novel method to detect microRNAs using chip-based QuantStudio 3D digital PCR
por: Conte, Davide, et al.
Publicado: (2015)

Therapeutic Use of MicroRNAs in Lung Cancer
por: Fortunato, Orazio, et al.
Publicado: (2014)

Cotargeting of miR‐126‐3p and miR‐221‐3p inhibits PIK3R2 and PTEN, reducing lung cancer growth and metastasis by blocking AKT and CXCR4 signalling
por: Di Paolo, Daniela, et al.
Publicado: (2021)

c-Myc shuttled by tumour-derived extracellular vesicles promotes lung bronchial cell proliferation through miR-19b and miR-92a
por: Borzi, Cristina, et al.
Publicado: (2019)

Metabolic classification of non-small cell lung cancer patient-derived xenografts by a digital pathology approach: A pilot study
por: Ferrarini, Federica, et al.
Publicado: (2023)

Inflammatory status and lung function predict mortality in lung cancer screening participants
por: Pastorino, Ugo, et al.
Publicado: (2018)

Timeline of SARS-CoV-2 Spread in Italy: Results from an Independent Serological Retesting
por: Montomoli, Emanuele, et al.
Publicado: (2021)

Development of a Molecular Blood-Based Immune Signature Classifier as Biomarker for Risks Assessment in Lung Cancer Screening
por: Fortunato, Orazio, et al.
Publicado: (2022)

Age-Related Alterations in Immune Contexture Are Associated with Aggressiveness in Rhabdomyosarcoma
por: Gasparini, Patrizia, et al.
Publicado: (2019)

C-reactive protein level predicts mortality in COPD: a systematic review and meta-analysis
por: Leuzzi, Giovanni, et al.
Publicado: (2017)

CXCR4 Inhibition Counteracts Immunosuppressive Properties of Metastatic NSCLC Stem Cells
por: Fortunato, Orazio, et al.
Publicado: (2020)

Differential glycosylation of collagen modulates lung cancer stem cell subsets through β1 integrin‐mediated interactions
por: Gardelli, Cecilia, et al.
Publicado: (2020)

YAP1 acts as oncogenic target of 11q22 amplification in multiple cancer subtypes
por: Lorenzetto, Erica, et al.
Publicado: (2014)

Pleural plaques in lung cancer screening by low-dose computed tomography: prevalence, association with lung cancer and mortality
por: Silva, Mario, et al.
Publicado: (2017)

Improved Prognostic Prediction in Never-Smoker Lung Cancer Patients by Integration of a Systemic Inflammation Marker with Tumor Immune Contexture Analysis
por: Milione, Massimo, et al.
Publicado: (2020)

Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy
por: Apolone, Giovanni, et al.
Publicado: (2020)

A novel CXCR4 antagonist counteracts paradoxical generation of cisplatin-induced pro-metastatic niches in lung cancer
por: Bertolini, Giulia, et al.
Publicado: (2021)

Beyond LKB1 Mutations in Non-Small Cell Lung Cancer: Defining LKB1less Phenotype to Optimize Patient Selection and Treatment
por: Borzi, Cristina, et al.
Publicado: (2020)

Establishment of a patient-derived intrahepatic cholangiocarcinoma xenograft model with KRAS mutation
por: Cavalloni, Giuliana, et al.
Publicado: (2016)

Diagnostic role of circulating extracellular matrix-related proteins in non-small cell lung cancer
por: Andriani, Francesca, et al.
Publicado: (2018)

CDCP1 is a novel marker of the most aggressive human triple-negative breast cancers
por: Turdo, Federica, et al.
Publicado: (2016)

Succinate Dehydrogenase B Subunit Immunohistochemical Expression Predicts Aggressiveness in Well Differentiated Neuroendocrine Tumors of the Ileum
por: Milione, Massimo, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_kbb8jholnjdpmfb3b1r1diud8n